Research in mice suggests that blocking, rather than activating the GLP-1 receptor may boost the immune response against colorectal cancer tumors
Sofia Spieler, a Boston public relations professional who has been losing weight on Wegovy, said her “snack monster” has essentially disappeared after she's had a lifelong sweet tooth.
By 2050, more than 6 in 10 U.S. adults will have heart disease, according to a new projection by the American Heart Association.